The role of glia in stress: Polyamines and brain disorders

Psychiatric Clinics of North America

Volumn 37, Issue 4, 2014, Pages 653-678

  Skatchkov, Serguei N ^a   Woodbury Fariña, Michel A ^b   Eaton, Misty ^a  

^a Universidad Central del Caribe School of Medicine   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Brain disorders; Glia; Polyamines; Stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CHLORPHENIRAMINE MALEATE PLUS PHENYLEPHRINE; DEXTRO SERINE; GAP JUNCTION PROTEIN; GLUTAMIC ACID; INWARDLY RECTIFYING POTASSIUM CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; ORGANIC CATION TRANSPORTER; ORNITHINE DECARBOXYLASE; POLYAMINE; SPERMIDINE; SPERMINE; TUMOR NECROSIS FACTOR ALPHA;

ASTROCYTE; BRAIN DISEASE; CELL COMMUNICATION; CELL LEVEL; EPENDYMA CELL; GLIA; HUMAN; MACROGLIA; MUELLER CELL; NERVE CELL; NERVE CELL NETWORK; NEUROMODULATION; OLIGODENDROGLIA; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; STRESS; TANYCYTE; ANIMAL; BRAIN; MENTAL STRESS; METABOLISM; RAT;

ANIMALS; BRAIN; BRAIN DISEASES; HUMANS; NEUROGLIA; POLYAMINES; RATS; STRESS, PSYCHOLOGICAL;

EID: 84921865442     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2014.08.008     Document Type: Review

References (310)

1. Ramón y Cajal S. Sobre un nuevo proceder de impregnación de la neuroglia y sus resultados en los centros nerviosos del hombre y animales. Trab Lab Invest Biol Univ Madrid 1913, 11:219-237. [in Spanish].
2. Somjen G.G. Nervenkitt: notes on the history of the concept of neuroglia. Glia 1988, 1(1):2-9.
3. Beatty J.T. The human brain: essentials of behavioral neuroscience 2001, Sage Publications Inc, Thousand Oaks (CA). 1st edition.
4. Berlucchi G. The origin of the term plasticity in the neurosciences: Ernesto Lugaro and chemical synaptic transmission. JHist Neurosci 2002, 11(3):305-309.
5. García-Marín V., García-López P., Freire M. Cajal's contributions to glia research. Trends Neurosci 2007, 30(9):479-487.
6. García-Marín V., García-López P., Freire M. Cajal's contributions to the study of Alzheimer's disease. JAlzheimers Dis 2007, 12(2):161-174.
7. DeFelipe J. Cajal and the discovery of a new artistic world: the neuronal forest. Prog Brain Res 2013, 203:201-220.
8. Chvátal A., Anderová M., Neprasová H., et al. Pathological potential of astroglia. Physiol Res 2008, 57(Suppl 3):S101-S110.
9. Parpura V., Verkhratsky A. Neuroglia at the crossroads of homoeostasis, metabolism and signalling: evolution of the concept. ASN Neuro 2012, 4(4):201-205.
10. Malatesta P., Hartfuss E., Götz M. Isolation of radial glial cells by fluorescent-activated cell sorting reveals a neuronal lineage. Development 2000, 127(24):5253-5263.
11. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., et al. Neurogenesis in the adult human hippocampus. Nat Med 1998, 4:1313-1317.
12. Kaplan M.S. Neurogenesis in the 3-month-old rat visual cortex. JComp Neurol 1981, 195(2):323-338.
13. Kriegstein A., Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 2009, 32:149-184.
14. Spassky N., Merkle F.T., Flames N., et al. Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis. JNeurosci 2005, 25(1):10-18.
15. Pilz G.A., Shitamukai A., Reillo I., et al. Amplification of progenitors in the mammalian telencephalon includes a new radial glial cell type. Nat Commun 2013, 4:2125.
16. Hagemann T.L., Paylor R., Messing A. Deficits in adult neurogenesis, contextual fear conditioning, and spatial learning in a Gfap mutant mouse model of Alexander disease. JNeurosci 2013, 33(47):18698-18706.
17. Betizeau M., Cortay V., Patti D., et al. Precursor diversity and complexity of lineage relationships in the outer subventricular zone of the primate. Neuron 2013, 80(2):442-457.
18. Piletz J.E., Aricioglu F., Cheng J.T., et al. Agmatine: clinical applications after 100 years in translation. Drug Discov Today 2013, 18(17-18):880-893.
19. Reichenbach A. Glia: neuron index: review and hypothesis to account for different values in various mammals. Glia 1989, 2:71-77.
20. Lent R., Azevedo F.A., Andrade-Moraes C.H., et al. How many neurons do you have? Some dogmas of quantitative neuroscience under revision. Eur J Neurosci 2012, 35(1):1-9.
21. Erlichman J.S., Leiter J.C., Gourine A.V. ATP, glia and central respiratory control. Respir Physiol Neurobiol 2010, 173(3):305-311.
22. Gourine A.V., Kasymov V., Marina N., et al. Astrocytes control breathing through pH-dependent release of ATP. Science 2010, 329(5991):571-575.
23. Laube G., Veh R.W. Astrocytes, not neurons, show most prominent staining for spermine/spermidine-like immunoreactivity in adult rat brain. Glia 1997, 19(2):171-179.
24. Biedermann B., Skatchkov S.N., Bringmann A., et al. Spermine/spermidine is expressed by retinal glial (Müller) cells, and controls distinct K+ channels of their membrane. Glia 1998, 23:209-220.
25. +- current rectification in frog retinal glial (Müller) cells. Glia 2000, 31:84-90.
26. Franze K., Grosche J., Skatchkov S.N., et al. Müller cells are living optical fibers in the vertebrate retina. PNAS 2007, 104:8287-8292.
27. Reichenbach A., Franze K., Agte S., et al. Live cells as optical fibers in the vertebrate retina. Selected topics on optical fiber technology 2012, 247-270. InTech. M. Yasin, S.W. Harun, H. Arof (Eds.).
28. Grishin E.V., Volkova T.M., Arsen'ev A.S., et al. Structural-functional characteristics of argiopine-the ion channel blockers from the spider Argiope lobata venom. Bioorg Khim 1986, 12(8):1121-1124. [in Russian].
29. Grishin E.V., Volkova T.M., Arsen'ev A.S. Glutamate receptor antagonists from the spider Argiope lobata venom. Bioorg Khim 1988, 14(7):883-892.
30. Antonov S.M., Grishin E.V., Magazanik L.G., et al. Argiopin blocks the glutamate responses and sensorimotor transmission in motoneurones of isolated frog spinal cord. Neurosci Lett 1987, 83(1-2):179-184.
31. Frølund S., Bella A., Kristensen A.S., et al. Assessment of structurally diverse philanthotoxin analogues for inhibitory activity on ionotropic glutamate receptor subtypes: discovery of nanomolar, nonselective, and use-dependent antagonists. JMed Chem 2010, 53(20):7441-7451.
32. Skatchkov S.N., Rojas L., Eaton M.J., et al. Functional expression of Kir 6.1/SUR1-Katp channels in frog retinal Müller glial cells. Glia 2002, 38:256-267.
33. Kucheryavykh Y.V., Shuba Y.M., Antonov S.M., et al. Complex rectification of Müller cell Kir currents. Glia 2008, 56:775-790.
34. Williams K. Modulation and block of ion channels: a new biology of polyamines. Cell Signal 1997, 9:1-13.
35. Haghighi A.P., Cooper E. Neuronal nicotinic acetylcholine receptors are blocked by intracellular spermine in a voltage-dependent manner. JNeurosci 1998, 18:4050-4062.
36. Bowie D., Mayer M.L. Inward rectification of both AMPA and kainate subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron 1995, 15:453-462.
37. + channels is caused by intracellular spermine. Cell 1995, 13:149-154.
38. Ahern G.P., Wang X., Miyares R.L. Polyamines are potent ligands for the capsaicin receptor TRPV1. JBiol Chem 2006, 281:8991-8995.
39. Lopatin A.N., Makhina E.N., Nichols C.G. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 1994, 372:366-369.
40. + channels to intracellular spermine. FEBS Lett 1994, 356:199-203.
41. Shao Z., Mellor I.R., Brierley M.J., et al. Potentiation and inhibition of nicotinic acetylcholine receptors by spermine in the TE671 human muscle cell line. JPharmacol Exp Ther 1998, 186:1269-1276.
42. Koh D.S., Burnashev N., Jonas P. Block of native Ca(2+)-permeable AMPA receptors in rat brain by intracellular polyamines generates double rectification. JPhysiol 1995, 486:305-312.
43. Koenig H., Goldstone A.D., Lu C.Y., et al. Brain polyamines are controlled by N-methyl-D-aspartate receptors during ischemia and recirculation. Stroke 1990, 21:III98-III102.
44. Lynch J.W. Rectification of the olfactory cyclic nucleotide-gated channel by intracellular polyamines. JMembr Biol 1999, 170:213-227.
45. Huang C.J., Moczydlowski E. Cytoplasmic polyamines as permeant blockers and modulators of the voltage-gated sodium channel. Biophys J 2001, 80:1262-1279.
46. Antonov S.M., Gmiro V.E., Johnson J.W. Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block. Nat Neurosci 1998, 1(6):451-461.
47. Davies M.S., Baganoff M.P., Grishin E.V., et al. Polyamine spider toxins are potent uncompetitive antagonists of rat cortex excitatory amino acid receptors. Eur J Pharmacol 1992, 227(1):51-56.
48. Donevan S.D., Rogawski M.A. Intracellular polyamines mediate inward rectification of Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Proc Natl Acad Sci USA 1995, 92:9298-9302.
49. Vataev S.I., Oganesian G.A., Lukomskaia N.I., et al. The action of ionotropic glutamate receptor channel blockers on effects of sleep deprivation in rats. Ross Fiziol Zh Im I M Sechenova 2013, 99(5):575-585. [in Russian].
50. Abushik P.A., Sibarov D.A., Eaton M.J., et al. Kainate-induced calcium overload of cortical neurons invitro: dependence on expression of AMPAR GluA2-subunit and down-regulation by subnanomolar ouabain. Cell Calcium 2013, 54(2):95-104.
51. Benveniste M., Mayer M.L. Multiple effects of spermine on N-methyl-D-aspartic acid receptor responses of rat cultured hippocampal neurones. JPhysiol 1993, 464:131-163.
52. Bahring R., Bowie D., Benveniste M., et al. Permeation and block of rat GluR6 glutamate receptor channels by internal and external polyamines. JPhysiol 1997, 502:575-589.
53. Araneda R.C., Lan J.Y., Zheng X., et al. Spermine and arcaine block and permeate N-methyl-D-aspartate receptor channels. Biophys J 1999, 76:2899-2911.
54. Quinn S.J., Ye C.P., Diaz R., et al. The Ca2+-sensing receptor: a target for polyamines. Am J Physiol 1997, 273:C1315-C1323.
55. Jiang X., Newell E.W., Schlichter L.C. Regulation of a TRPM7-like current in rat brain microglia. JBiol Chem 2003, 278:42867-42876.
56. Rozov A., Burnashev N. Polyamine-dependent facilitation of postsynaptic AMPA receptors counteracts paired-pulse depression. Nature 1999, 401:594-598.
57. Isa T., Iion M., Itazawa S., et al. Spermine mediates inward rectification of Ca(2+)-permeable AMPA receptor channels. Neuroreport 1996, 6:2045-2048.
58. Mott D.D., Washburn M.S., Zhang S., et al. Subunit-dependent modulation of kainate receptors by extracellular protons and polyamines. JNeurosci 2003, 23:1179-1188.
59. Lindquist T.D., Sturman J.A., Gould R.M., et al. Axonal transport of polyamines in intact and regenerating axons of the rat sciatic nerve. JNeurochem 1985, 44:1913-1919.
60. Gilad G.M., Balakrishnan K., Gilad V.H. The course of putrescine immunocytochemical appearance in neurons, astroglia and microglia in rat brain cultures. Neurosci Lett 1999, 268:33-36.
61. Araque A., Parpura V., Sanzgiri R.P., et al. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999, 22:208-215.
62. Perea G., Araque A. Astrocytes potentiate transmitter release at single hippocampal synapses. Science 2007, 317:1083-1086.
63. Bacaj T., Tevlin M., Lu Y., et al. Glia are essential for sensory organ function in C. elegans. Science 2008, 322:744-747.
64. Keyser D.O., Pellmar T.C. Synaptic transmission in the hippocampus: critical role of glia. Glia 1994, 10:237-243.
65. Fonnum F., Johnsen A., Hassel B. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia 1997, 21:106-113.
66. Zonta M., Angulo M.C., Gobbo S., et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 2003, 6:43-50.
67. Attwell D., Buchan A.M., Charpak S., et al. Glial and neuronal control of brain blood flow. Nature 2010, 468(7321):232-243.
68. Norenberg M.D., Neary J.T., Bender A.S., et al. Hepatic encephalopathy: a disorder in glial-neuronal communication. Prog Brain Res 1992, 94:261-269.
69. Dubois-Dauphin M., Poitry-Yamate C., de Bilbao F., et al. Early postnatal Müller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice. Neuroscience 2000, 95:9-21.
70. Orkand R.K., Nicholls J.G., Kuffler S.W. Effect of nerve impulses on the membrane potential of glial cells in the central nervous system of amphibia. JNeurophysiol 1966, 29:788-806.
71. Newman E.A., Frambach D.A., Odette L.L. Control of extracellular potassium levels by retinal glial cell K+ siphoning. Science 1984, 225(4667):1174-1175.
72. Kofuji P., Ceelen P., Zahs K.R., et al. Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina. JNeurosci 2000, 20:5733-5740.
73. Kucheryavykh Y.V., Kucheryavykh L.Y., Nichols C.G., et al. Downregulation of Kir4.1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes. Glia 2007, 55:274-281.
74. Djukic B., Casper J.B., Philpot B.D., et al. Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. JNeurosci 2007, 27:11354-11365.
75. Stevens E.R., Esguerra M., Kim P.M., et al. D-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors. Proc Natl Acad Sci USA 2003, 100(11):6789-6794.
76. Newman E.A. Glial cell inhibition of neurons by release of ATP. JNeurosci 2003, 23:1659-1666.
77. Newman E.A. Glial control of synaptic transmission in the retina. Glia 2004, 47:268-274.
78. Parpura V., Basarsky T.A., Liu F., et al. Glutamate-mediated astrocyte-neuron signaling. Nature 1994, 369:744-747.
79. Araque A., Carmignoto G., Haydon P.G. Dynamic signaling between astrocytes and neurons. Annu Rev Physiol 2001, 63:795-813.
80. Ye Z.C., Wyeth M.S., Baltan-Tekkok S., et al. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. JNeurosci 2003, 23:3588-3596.
81. Filosa J.A., Bonev A.D., Straub S.V., et al. Local potassium signaling couples neuronal activity to vasodilation in the brain. Nat Neurosci 2006, 9:1397-1403.
82. Metea M.R., Kofuji P., Newman E.A. Neurovascular coupling is not mediated by potassium siphoning from glial cells. JNeurosci 2007, 27:2468-2471.
83. Miller R.F. D-Serine as a glial modulator of nerve cells. Glia 2005, 47(3):275-283.
84. Sullivan S.J., Miller R.F. AMPA receptor-dependent, light-evoked D-serine release acts on retinal ganglion cell NMDA receptors. JNeurophysiol 2012, 108(4):1044-1051.
85. Viviani B., Corsini E., Galli C.L., et al. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 1998, 150(2):271-276.
86. Halassa M.M., Fellin T., Haydon P.G. Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 2009, 57(4):343-346.
87. Burnashev N. Dynamic modulation of AMPA receptor mediated synaptic transmission by polyamines in principal neurons. Focus on polyamines modulate AMPA receptor-dependent synaptic response in immature layer V pyramidal neurons. JNeurophysiol 2005, 93:2371-2386.
88. Washburn M.S., Numberger M., Zhang S., et al. Differential dependence on GluR2 expression of three characteristic features of AMPA receptors. JNeurosci 1997, 17:9393-9406.
89. Noh K.M., Yokota H., Mashiko T., et al. Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc Natl Acad Sci USA 2005, 102:12230-12235.
90. Mulle C., Sailer A., Swanson G.T., et al. Subunit composition of kainate receptors in hippocampal interneurons. Neuron 2000, 28:475-484.
91. Liu B., Liao M., Mielke J.G., et al. Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. JNeurosci 2006, 26:5309-5319.
92. Bell J.D., Ai J., Chen Y., et al. Mild invitro trauma induces rapid GluR-2 endocytosis, robustly augments calcium permeability and enhances susceptibility to secondary excitotoxic insult in cultured Purkinje cells. Brain 2007, 130:2528-2542.
93. Dingledine R., Borges K., Bowie D., et al. The glutamate receptor ion channels. Pharmacol Rev 1999, 51(1):7-61.
94. Bowie D. Redefining the classification of AMPA-selective ionotropic glutamate receptors. JPhysiol 2012, 590(Pt 1):49-61.
95. Sibarov D.A., Bolshakov A.E., Abushik P.A., et al. Na+,K+-ATPase functionally interacts with the plasma membrane Na+,Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress. JPharmacol Exp Ther 2012, 343(3):596-607.
96. Eisenberg T., Knauer H., Schauer A., et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 2009, 11(11):1305-1314.
97. Soda K., Dobashi Y., Kano Y., et al. Polyamine-rich food decreases age-associated pathology and mortality in aged mice. Exp Gerontol 2009, 44(11):727-732.
98. Soda K. Polyamine intake, dietary pattern, and cardiovascular disease. Med Hypotheses 2010, 75(3):299-301.
99. Soda K., Kano Y., Chiba F., et al. Increased polyamine intake inhibits age-associated alteration in global DNA methylation and 1,2-dimethylhydrazine-induced tumorigenesis. PLoS One 2013, 8(5):e64357.
100. Gupta V.K., Scheunemann L., Eisenberg T., et al. Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. Nat Neurosci 2013, 16:1453-1460.
101. Liu P., Fleete M.S., Jing Y., et al. Altered arginine metabolism in Alzheimer's disease brains. Neurobiol Aging 2014, 35(9):1992-2003.
102. Cervós-Navarro J., Diemer N.H. Selective vulnerability in brain hypoxia. Crit Rev Neurobiol 1991, 6:149-182.
103. Velloso N.A., Dalmolin G.D., Fonini G., et al. Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats. Brain Res 2008, 1198:107-114.
104. Benedikt J., Inyushin M., Kucheryavykh Y.V., et al. Intracellular polyamines enhance astrocytic coupling. Neuroreport 2012, 23(17):1021-1025.
105. Shalaby I.A., Chenard B.L., Prochniak M.A., et al. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82, 0715 on hippocampal cells in culture. JPharmacol Exp Ther 1992, 260:925-932.
106. Sparapani M., Dall'Olio R., Gandolfi O., et al. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells. Exp Neurol 1997, 148:157-166.
107. Adachi K., Izumi M., Osano Y., et al. Polyamine concentrations in the brain of vitamin B12-deficient rats. Exp Biol Med 2003, 228:1069-1071.
108. Ferchmin P.A., Pérez D., Biello M. Spermine is neuroprotective against anoxia and N-methyl-D-aspartate in hippocampal slices. Brain Res 2000, 859:273-279.
109. Gilad G.M., Gilad V.H. Polyamines can protect against ischemia-induced nerve cell death in gerbil forebrain. Exp Neurol 1991, 111:349-355.
110. Watanabe S., Kusama-Eguchi K., Kobayashi H., et al. Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. JBiol Chem 1991, 266:20803-20809.
111. Seiler N. Formation, catabolism and properties of the natural polyamines. The neuropharmacology of polyamines 1994, 1-36. Academic; Harcourt Brace, New York; London. C. Carter (Ed.).
112. Seiler N., Delcros J.G., Moulinoux J.P. Polyamine transport in mammalian cells. An update. Int J Biochem Cell Biol 1996, 28:843-861.
113. Masuko T., Kusama-Eguchi K., Sakata K., et al. Polyamine transport, accumulation and release in brain. JNeurochem 2003, 84:610-617.
114. Ingoglia N.A., Sturman J.A., Eisner R.A. Axonal transport of putrescine, spermidine and spermine in normal and regenerating goldfish optic nerve. Brain Res 1977, 130:433-445.
115. Ingoglia N.A., Sharma S.C., Pilchman J., et al. Axonal transport and transcellular transfer of nucleosides and polyamines in intact and regenerating optic nerves of goldfish: speculation on the axonal regulation of periaxonal cell metabolism. JNeurosci 1982, 2:1412-1423.
116. Ingoglia N.A., Sturman J.A., Jaggard P., et al. Association of spermine and 4S RNA during axonal transport in regenerating optic nerves of goldfish. Brain Res 1982, 238:341-351.
117. Cohen S.S. Introduction to the polyamines 1971, Prentice-Hall, Englewood Cliffs (NJ).
118. Wallace H.M. The polyamines: past, present and future. Essays Biochem 2009, 46:1-9.
119. Krauss M., Langnaese K., Richter K., et al. Spermidine synthase is prominently expressed in the striatal patch compartment and in putative interneurons of matrix compartments. JNeurochem 2006, 1:174-189.
120. Krauss M., Weiss T., Langnaese K., et al. Cellular and subcellular rat brain spermidine synthase expression patterns suggest region-specific roles for polyamines, including cerebellar pre-synaptic function. JNeurochem 2007, 103:679-693.
121. Gilad G.M., Gilad V.H. Polyamine uptake, binding and release in rat brain. Eur J Pharmacol 1991, 193(1):41-46.
122. Laschet J., Grisar T., Bureau M., et al. Characteristics of putrescine uptake and subsequent GABA formation in primary cultured astrocytes from normal C57BL/6J and epileptic DBA/2J mouse brain cortices. Neuroscience 1992, 48:151-157.
123. Laschet J., Trottier S., Leviel V., et al. Heterogeneous distribution of polyamines in temporal lobe epilepsy. Epilepsy Res 1999, 35:161-172.
124. Dot J., Lluch M., Blanco I., et al. Polyamine uptake in cultured astrocytes: characterization and modulation by protein kinases. JNeurochem 2000, 75:1917-1926.
125. Dot J., Danchev N., Blanco I., et al. Polyamine uptake is necessary for a normal biochemical maturation of astrocytes in culture. Neuroreport 2002, 13:1083-1087.
126. De La Hera D.P., Corradi G.R., Adamo H.P., et al. Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake. Biochem J 2013, 450(1):47-53.
127. Valentino T.L., Lukasiewicz P.D., Romano C. Immunocytochemical localization of polyamines in tiger salamander retina. Brain Res 1996, 713:278-285.
128. Cintra A., Fuxe K., Agnati L.F., et al. Evidence for the existence of ornithine decarboxylase-immunoreactive neurons in the rat brain. Neurosci Lett 1987, 76:269-274.
129. Dorn A., Müller M., Bernstein H.G., et al. Immunohistochemical localization of L-ornithine decarboxylase in developing rat brain. Int J Dev Neurosci 1987, 5:145-150.
130. Fujiwara K., Bai G., Kitagawa T. Polyamine-like immunoreactivity in rat neurons. Brain Res 1997, 767:166-171.
131. Soulet D., Gagnon B., Rivest S., et al. Afluorescent probe of polyamine transport accumulates into intracellular acidic vesicles via a two-step mechanism. JBiol Chem 2004, 279(47):49355-49366.
132. Poulin R., Casero R.A., Soulet D. Recent advances in the molecular biology of metazoan polyamine transport. Amino Acids 2012, 42(2-3):711-723.
133. De Keyser J., Mostert J.P., Koch M.W. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. JNeurol Sci 2008, 267(1-2):3-16.
134. Ricci G., Volpi L., Pasquali L., et al. Astrocyte-neuron interactions in neurological disorders. JBiol Phys 2009, 35(4):317-336.
135. Suzuki M., Van Paesschen W., Stalmans I., et al. Defective membrane expression of the Na(+)-HCO(3)(-) cotransporter NBCe1 is associated with familial migraine. Proc Natl Acad Sci USA 2010, 107(36):15963-15968.
136. Neuroglia 2012, Oxford University Press, New York. 3rd edition. H. Kettenmann, B.R. Ransom (Eds.).
137. Cooper M.S. Intercellular signaling in neuronal-glial networks. Biosystems 1995, 34(1-3):65-85.
138. Cooper Z.D., Jones J.D., Comer S.D. Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opin Investig Drugs 2012, 21(2):169-178.
139. Verkhratsky A., Orkand R.K., Kettenmann H. Glial calcium: homeostasis and signaling function. Physiol Rev 1998, 78(1):99-141.
140. Verkhratsky A., Noda M., Parpura V., et al. Sodium fluxes and astroglial function. Adv Exp Med Biol 2013, 961:295-305.
141. Verkhratsky A., Rodríguez J.J., Parpura V. Astroglia in neurological diseases. Future Neurol 2013, 8(2):149-158.
142. Verkhratsky A., Rodríguez J.J., Steardo L. Astrogliopathology: a central element of neuropsychiatric diseases?. Neuroscientist 2013, [Epub ahead of print].
143. Seidl R., Beninati S., Cairns N., et al. Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease. Neurosci Lett 1996, 206(2-3):193-195.
144. Seitz R., Ohlmann A., Tamm E.R. The role of Müller glia and microglia in glaucoma. Cell Tissue Res 2013, 353(2):339-345.
145. Turner J.R., Ecke L.E., Briand L.A., et al. Cocaine-related behaviors in mice with deficient gliotransmission. Psychopharmacology (Berl) 2013, 226(1):167-176.
146. Dalkara T., Kiliç K. How does fasting trigger migraine? A hypothesis. Curr Pain Headache Rep 2013, 17(10):368.
147. Zeidán-Chuliá F., Salmina A.B., Malinovskaya N.A., et al. The glial perspective of autism spectrum disorders. Neurosci Biobehav Rev 2014, 38:160-172.
148. Scofield M.D., Kalivas P.W. Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis. Neuroscientist 2014, [Epub ahead of print].
149. Clasadonte J., McIver S.R., Schmitt L.I., et al. Chronic sleep restriction disrupts sleep homeostasis and behavioral sensitivity to alcohol by reducing the extracellular accumulation of adenosine. JNeurosci 2014, 34(5):1879-1891.
150. Jo W.K., Law A.C., Chung S.K. The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders. Mol Psychiatry 2014, 19(2):159-167.
151. Classic pages in obstetrics and gynecology. Observationes...de natis è seminegenitali animalculis. Antoni Van Leeuwenhoek. Philosophical Transactions of the Royal Society (London), vol. 12, pp. 1040-1043, 1678-1679. Am J Obstet Gynecol 1978, 131(4):469-470.
152. Dudley H.W., Rosenheim O., Starling W.W. The chemical constitution of spermine. III. Structure and synthesis. Biochem J 1926, 20:1082-1094.
153. Bachrach U. The early history of polyamine research. Plant Physiol Biochem 2010, 48(7):490-495.
154. Redgate E.S., Boggs S., Grudziak A., et al. Polyamines in brain tumor therapy. JNeurooncol 1995, 25:167-179.
155. Minois N. Molecular basis of the 'anti-aging' effect of spermidine and other natural polyamines-a mini-review. Gerontology 2014, 60(4):319-326.
156. LaRocca T.J., Gioscia-Ryan R.A., Hearon C.M., et al. The autophagy enhancer spermidine reverses arterial aging. Mech Ageing Dev 2013, 134(7-8):314-320.
157. Heby O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation 1981, 19:1-20.
158. Johnson T.D. Modulation of channel function by polyamines. Trends Pharmacol Sci 1996, 17:22-27.
159. Nichols C.G., Lopatin A.N. Inward rectifier potassium channels. Annu Rev Physiol 1997, 59:171-191.
160. Skatchkov S.N., Buldakova S., Kucheryavykh Y.V., et al. Neuronal network regulation in ca1 hippocampus: role of glial polyamines and hemichannels. JNeurochem 2006, 96(Suppl 1, Symposium 08):138.
161. Rubin M.A., Boemo R.L., Jurach A., et al. Intrahippocampal spermidine administration improves inhibitory avoidance performance in rats. Behav Pharmacol 2000, 11:57-62.
162. Rubin M.A., Stiegemeier J.A., Volkweis M.A., et al. Intra-amygdala spermidine administration improves inhibitory avoidance performance in rats. Eur J Pharmacol 2001, 423:35-39.
163. Rubin M.A., Berlese D.B., Stiegemeier J.A., et al. Intra-amygdala administration of polyamines modulates fear conditioning in rats. JNeurosci 2004, 24:2328-2334.
164. Velloso N.A., Dalmolin G.D., Gomes G.M., et al. Spermine improves recognition memory deficit in a rodent model of Huntington's disease. Neurobiol Learn Mem 2009, 92(4):574-580.
165. Genedani S., Piccinini G., Bertolini A. Putrescine has analgesic activity, in rats. Life Sci 1984, 34:2407-2412.
166. Kolhekar R., Meller S.T., Gephart G.F. N-methyl-D-aspartate receptor-mediated changes in thermal nociception: allosteric modulation at glycine and polyamine recognition sites. Neuroscience 1994, 63:925-936.
167. Adibhatla R.M., Hatcher J.F., Sailor K., et al. Polyamines and central nervous system injury: spermine and spermidine decrease following transient focal cerebral ischemia in spontaneously hypertensive rats. Brain Res 2002, 938:81-86.
168. Clarkson A.N., Liu H., Pearson L., et al. Neuroprotective effects of spermine following hypoxic-ischemic-induced brain damage: a mechanistic study. FASEB J 2004, 2004(18):1114-1116.
169. Yin H.Z., Tang D.T., Weiss J.H. Intrathecal infusion of a Ca(2+)-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS. Exp Neurol 2007, 207:177-185.
170. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998, 95(22):13290-13295.
171. Zomkowski A.D., Santos A.R., Rodrigues A.L. Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog Neuropsychopharmacol Biol Psychiatry 2005, 30:1419-1425.
172. Bellé N.A., Dalmolin G.D., Fonini G., et al. Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res 2004, 1008:245-251.
173. Shaw G.G., Pateman A.J. The regional distribution of the polyamines spermidine and spermine in brain. JNeurochem 1973, 20:1225-1230.
174. Halaris A., Piletz J.E. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress. Ann N Y Acad Sci 2003, 1009:1-20.
175. Peters D., Berger J., Langnaese K., et al. Arginase and arginine decarboxylase-where do the putative gate keepers of polyamine synthesis reside in rat brain?. PLoS One 2013, 8(6):e66735.
176. Bernstein H.G., Müller M. The cellular localization of L-ornithine decarboxylase-polyamine system in the normal and diseased central nervous system. Prog Neurobiol 1999, 57:485-505.
177. Bernstein H.G., Steiner J., Bogerts B. Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev Neurother 2009, 9(7):1059-1071.
178. Bernstein H.G., Derst C., Stich C., et al. The agmatine-degrading enzyme agmatinase: a key to agmatine signaling in rat and human brain?. Amino Acids 2011, 40:453-465.
179. Bernstein H.G., Stich C., Jäger K., et al. Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology 2012, 62(1):237-246.
180. Abdulhussein A.A., Wallace H.M. Polyamines and membrane transporters. Amino Acids 2014, 46(3):655-660.
181. Pegg A.E. Mammalian polyamine metabolism and function. IUBMB Life 2009, 61:880-894.
182. Pegg A.E. The function of spermine. IUBMB Life 2014, 66(1):8-18.
183. Virgili M., Crochemore C., Pena-Altamira E., et al. Regional and temporal alterations of ODC/polyamine system during ALS-like neurodegenerative motor syndrome in G93A transgenic mice. Neurochem Int 2006, 48:201-207.
184. Tracey K.J. The inflammatory reflex. Nature 2002, 429:853-859.
185. Sequeira A., Gwadry F.G., Ffrench-Mullen J.M., et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006, 63:35-48.
186. Withrow C., Ashraf S., O'Leary T., et al. Effect of polyamine depletion on cone photoreceptors of the developing rabbit retina. Invest Ophthalmol Vis Sci 2002, 43:3081-3090.
187. Jänne J., Alhonen L., Keinänen T.A., et al. Animal disease models generated bygenetic engineering of polyamine metabolism. JCell Mol Med 2005, 9:865-882.
188. Jänne J., Alhonen L., Pietilä M., et al. Genetic manipulation of polyamine catabolism in rodents. JBiochem 2006, 139:155-160.
189. Madai V.I., Poller W.C., Peters D., et al. Synaptic localisation of agmatinase in rat cerebral cortex revealed by virtual pre-embedding. Amino Acids 2012, 43(3):1399-1403.
190. Gilad G.M., Gilad V.H., Finberg J.P., et al. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. Neurochem Res 2005, 30(6-7):713-719.
191. Inazu M., Takeda H., Maehara K., et al. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. JNeurochem 2006, 97:424-434.
192. Sala-Rabanal M., Li D.C., Inyushin M., et al. Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2 and OCT3. Mol Pharm 2013, 10(4):1450-1458.
193. Medeiros R., Laferla F.M. Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 2012, 239:133-138.
194. Iliff J.J., Wang M., Liao Y., et al. Aparavascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 2012, 4(147):147ra111.
195. Sigrist S.J., Carmona-Gutierrez D., Gupta V.K., et al. Spermidine-triggered autophagy ameliorates memory during aging. Autophagy 2014, 10(1):178-179.
196. Nilsen L.H., Witter M.P., Sonnewald U. Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease. JCereb Blood Flow Metab 2014, 10.1038/jcbfm.2014.37.
197. Johansson A., Engler H., Blomquist G., et al. Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET. JNeurol Sci 2007, 255(1-2):17-22.
198. Martorana F., Brambilla L., Valori C.F., et al. The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Hum Mol Genet 2012, 21(4):826-840.
199. Sunyach C., Michaud M., Arnoux T., et al. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model. Neuropharmacology 2012, 62(7):2346-2352.
200. Messing A., Brenner M., Feany M.B., et al. Alexander disease. JNeurosci 2012, 32(15):5017-5023.
201. Vila M., Jackson-Lewis V., Guégan C., et al. The role of glial cells in Parkinson's disease. Curr Opin Neurol 2001, 14(4):483-489.
202. Rempe D.A., Nedergaard M. Targeting glia for treatment of neurological disease. Neurotherapeutics 2010, 7(4):335-337.
203. Cisbani G., Freeman T.B., Soulet D., et al. Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability. Brain 2013, 136(Pt 2):433-443.
204. Chakraborty J., Singh R., Dutta D., et al. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's disease. CNS Neurosci Ther 2014, 20(1):10-19.
205. Srivastava R., Aslam M., Kalluri S.R., et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. NEngl J Med 2012, 367:115-123.
206. Palumbo S., Bosetti F. Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: role of cyclooxygenase-2. Prostaglandins Leukot Essent Fatty Acids 2013, 89(5):273-278.
207. Hinterkeuser S., Schroder W., Hager J.G., et al. Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances. Eur J Neurosci 2000, 12:2087-2096.
208. Bockenhauer D., Feather S., Stanescu H.C., et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. NEngl J Med 2009, 360:1960-1970.
209. Inyushin M., Kucheryavykh L.Y., Kucheryavykh Y.V., et al. Potassium channel activity and glutamate uptake are impaired in astrocytes of seizure susceptible DBA/2 mice. Epilepsia 2010, 51(9):1707-1713.
210. Sala-Rabanal M., Kucheryavykh L.Y., Skatchkov S.N., et al. Molecular mechanisms of EAST/SeSAME syndrome mutations in Kir4.1 (KCNJ10). JBiol Chem 2010, 285:36040-36048.
211. Wallraff A., Köhling R., Heinemann U., et al. The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. JNeurosci 2006, 26:5438-5447.
212. Steinhäuser C., Seifert G., Bedner P. Astrocyte dysfunction in temporal lobe epilepsy: K+ channels and gap junction coupling. Glia 2012, 60:1192-1202.
213. Steinhäuser C., Boison D. Epilepsy: crucial role for astrocytes. Glia 2012, 60(8):1191.
214. Boison D. Adenosine dysfunction in epilepsy. Glia 2012, 60(8):1234-1243.
215. Hines D.J., Schmitt L.I., Hines R.M., et al. Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling. Transl Psychiatry 2013, 3:e212.
216. Takano K., Ogura M., Nakamura Y., et al. Neuronal and glial responses to polyamines in the ischemic brain. Curr Neurovasc Res 2005, 2(3):213-223.
217. D'Ambrosio R., Maris D.O., Grady M.S., et al. Impaired K(+) homeostasis and altered electrophysiological properties of post-traumatic hippocampal glia. JNeurosci 1999, 19(18):8152-8162.
218. Zhang R.L., Zhang Z.G., Wang Y., et al. Stroke induces ependymal cell transformation into radial glia in the subventricular zone of the adult rodent brain. JCereb Blood Flow Metab 2007, 27(6):1201-1212.
219. Kucheryavykh L.Y., Kucheryavykh Y.V., Inyushin M., et al. Ischemia increases TREK-2 channel expression in astrocytes: relevance to glutamate clearance. Open Neurosci J 2009, 3:40-47.
220. Quirié A., Demougeot C., Bertrand N., et al. Effect of stroke on arginase expression and localization in the rat brain. Eur J Neurosci 2013, 37(7):1193-1202.
221. Sword J., Masuda T., Croom D., et al. Evolution of neuronal and astroglial disruption in the peri-contusional cortex of mice revealed by invivo two-photon imaging. Brain 2013, 136(Pt 5):1446-1461.
222. Zhang M., Caragine T., Wang H., et al. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. JExp Med 1997, 185(10):1759-1768.
223. Zhang M., Borovikova L.V., Wang H., et al. Spermine inhibition of monocyte activation and inflammation. Mol Med 1999, 55:595-605.
224. Olsen M.L., Sontheimer H. Mislocalization of Kir channels in malignant glia. Glia 2004, 46(1):63-73.
225. Olsen M.L., Sontheimer H. Functional implications for Kir4.1 channels in glial biology: from K+ buffering to cell differentiation. JNeurochem 2008, 107:589-601.
226. Kucheryavykh L, Rolón-Reyes K, Kucheryavykh Y, etal. Glioblastoma development in mouse brain: general reduction of OCTs and mislocalization of OCT3 transporter and subsequent uptake of ASP+ substrate to the nuclei. J Neurosci Neuroeng 2014;3(1):3-9.
227. Goodenberger M.L., Jenkins R.B. Genetics of adult glioma. Cancer Genet 2012, 205(12):613-621.
228. Nelson P.G., McCune S.K., Ades A.M., et al. Glial-neurotrophic mechanisms in Down syndrome. JNeural Transm 2001, (61):85-94.
229. Cason A.L., Ikeguchi Y., Skinner C., et al. X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome. Eur J Hum Genet 2003, 11:937-944.
230. Ikeguchi Y., Bewley M.C., Pegg A.E. Aminopropyltransferases: function, structure and genetics. JBiochem 2006, 139:1-9.
231. Scholl U.I., Choi M., Liu T., et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci USA 2009, 106(14):5842-5847.
232. Iliff J.J., Nedergaard M. Alink between glial Ca2+ signaling and hypoxia in aging?. JCereb Blood Flow Metab 2013, 33(2):170.
233. Kilpeläinen P., Rybnikova E., Hietala O., et al. Expression of ODC and its regulatory protein antizyme in the adult rat brain. JNeurosci Res 2000, 62:675-685.
234. Junttila T., Hietanen-Peltola M., Rechardt L., et al. Ornithine decarboxylase-like immunoreactivity in rat spinal motoneurons and motoric nerves. Brain Res 1993, 609:149-153.
235. Stout C.E., Costatin J.L., Naus C.C., et al. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. JBiol Chem 2002, 277:10482-10488.
236. Contreras J.E., Sáez J.C., Bukauskas F.F., et al. Functioning of Cx43 hemichannels demonstrated by single channel properties. Cell Commun Adhes 2003, 10:245-249.
237. Pannicke T., Faude F., Reichenbach A., et al. Afunction of delayed rectifier potassium channels in glial cells: maintenance of an auxiliary membrane potential under pathological conditions. Brain Res 2000, 862:187-193.
238. Zhou M., Kimelberg H.K. Freshly isolated hippocampal CA1 astrocytes comprise two populations differing in glutamate transporter and AMPA receptor expression. JNeurosci 2001, 21:7901-7908.
239. Bao L., Locovei S., Dahl G. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett 2004, 572:65-68.
240. Huang Y., Grinspan J.B., Abrams C.K., et al. Pannexin1 is expressed by neurons and glia but does not form functional gap junctions. Glia 2007, 55:46-56.
241. Makarov V., Kucheryavykh L., Kucheryavykh Y., et al. Transport reversal during heteroexchange: a kinetic study. JBiophys 2013, 2013:683256.
242. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000, 403:316-321.
243. Sulzer D., Chen T.K., Lau Y.Y., et al. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. JNeurosci 1995, 15:4102-4108.
244. Sulzer D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 2011, 69(4):628-649.
245. Kucheryavykh Y.V., Pearson W.L., Kurata H., et al. Unique features of Kir4.1 channel rectification. Channels (Austin) 2007, 1:172-178.
246. Lalo U., Palygin O., Rasooli-Nejad S., et al. Exocytosis of ATP from astrocytes modulates phasic and tonic inhibition in the neocortex. PLoS Biol 2014, 12(1):e1001747.
247. Iglesias R., Dahl G., Qiu F., et al. Pannexin 1: the molecular substrate of astrocyte "hemichannels". JNeurosci 2009, 29:7092-7097.
248. Wang F., Smith N.A., Xu Q., et al. Photolysis of caged Ca2+ but not receptor-mediated Ca2+ signaling triggers astrocytic glutamate release. JNeurosci 2013, 33(44):17404-17412.
249. Bennett M.V., Contreras J.E., Bukauskas F.F., et al. New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci 2003, 26:610-617.
250. Bennett M.V., Garré J.M., Orellana J.A., et al. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons. Brain Res 2012, 1487:3-15.
251. Enkvetchakul D., Ebihara L., Nichols C.G. Polyamine flux in Xenopus oocytes through hemi-gap junctional channels. JPhysiol 2003, 553(Pt 1):95-100.
252. Musa H., Veenstra R.D. Voltage-dependent blockade of connexin40 gap junctions by spermine. Biophys J 2003, 84:205-219.
253. Musa H., Fenn E., Crye M., et al. Amino terminal glutamate residues confer spermine sensitivity and affect voltage gating and channel conductance of rat connexin40 gap junctions. JPhysiol 2004, 557:863-878.
254. Pelegrin P., Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1b release by the ATP-gated P2X7 receptor. EMBO J 2006, 25:5071-5082.
255. Skatchkov SN, Inyushin M, Kucheryavykh YV, etal. Multiple pathways of polyamine accumulation in glia. Proceedings of the Annual Meetings of Society for Neuroscience. SFN Abstr. 138.7. Chicago (IL); 2009.
256. Alvarez-Maubecin V., Garcia-Hernandez F., Williams J.T., et al. Functional coupling between neurons and glia. JNeurosci 2000, 20:4091-4098.
257. Rivera Y, YV Kucheryavykh, J Benedikt, etal. Polyamine fluxes through Cx43-hemichannels in freshly isolated astrocytes and Müller glia. Proceedings of the Annual Meetings of Society for Neuroscience. SFN Abstr. 536.16. New Orleans (LA); 2012.
258. Rivera Y, Inyushin M, Kucheryavykh YV, etal. Pathways for physiological accumulation of polyamines in astrocytes. Proceedings of the Annual Meetings of Society for Neuroscience. SFN Abstr. 521.06. San Diego (CA): 2013.
259. Busch A.E., Wuester S., Ulzheimer J.C., et al. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. JBiol Chem 1996, 271:32599-32604.
260. Gründemann D., Koster S., Kiefer N., et al. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. JBiol Chem 1998, 273:30915-30920.
261. Gründemann D., Schömig E. Gene structures of the human non-neuronal monoamine transporters EMT and OCT2. Hum Genet 2000, 106:627-635.
262. Schömig E., Spitzenberger F., Engelhardt M., et al. Molecular cloning and characterization of two novel transport proteins from rat kidney. FEBS Lett 1998, 425:79-86.
263. Koepsell H., Lips K., Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007, 24:1227-1251.
264. Takeda H., Inazu M., Matsumiya T. Astroglial dopamine transport is mediated by norepinephrine transporter. Naunyn Schmiedebergs Arch Pharmacol 2002, 366:620-623.
265. Inazu M., Takeda H., Matsumiya T. The role of glial monoamine transporters in the central nervous system. Nihon Shinkei Seishin Yakurigaku Zasshi 2003, 23:171-178.
266. Inyushin M., Kucheryaykh Y., Kucheryavykh L., et al. Membrane potential and pH-dependent accumulation of decynium-22 (1,1'-diethyl-2,2'-cyanine iodide) fluorescence through OCT transporters in astrocytes. Bol Asoc Med P R 2010, 102(3):5-12.
267. Autere A.M., Lamsa K., Kaila K., et al. Synaptic activation of GABAA receptors induces neuronal uptake of Ca2+ in adult rat hippocampal slices. JNeurophysiol 1999, 81:811-816.
268. 2+ influx in hippocampal CA1 pyramidal neurons via extracellular carbonic anhydrase. JNeurosci 2007, 27:1167-1175.
269. Ballanyi K., Grafe P., Ten Bruggencate G. Ion activities and potassium uptake mechanisms of glial cells in guinea-pig olfactory cortex slices. JPhysiol 1987, 382:159-174.
270. Siemkowicz E., Hansen A.J. Brain extracellular ion composition and EEG activity following 10 minutes ischemia in normo- and hyperglycemic rats. Stroke 1981, 12(2):236-240.
271. Nilsson P., Laursen H., Hillered L., et al. Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels. JCereb Blood Flow Metab 1996, 16(2):262-270.
272. Hansen A.J., Nedergaard M. Brain ion homeostasis in cerebral ischemia. Neurochem Pathol 1988, 9:195-209.
273. Hansen A.J., Zeuthen T. Extracellular ion concentrations during spreading depression and ischemia in the rat brain cortex. Acta Physiol Scand 1981, 113(4):437-445.
274. Parpura V., Scemes E., Spray D.C. Mechanisms of glutamate release from astrocytes: gap junction "hemichannels", purinergic receptors and exocytotic release. Neurochem Int 2004, 45:259-264.
275. Spray D.C., Ye Z.C., Ransom B.R. Functional connexin "hemichannels": a critical appraisal. Glia 2006, 54(7):758-773.
276. Roth M., Obaidat A., Hagenbuch B. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 2012, 165(5):1260-1287.
277. Ivanova S., Botchkina G.I., Al-Abed Y., et al. Identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. JExp Med 1998, 188:327-340.
278. Bell M.R., Belarde J.A., Johnson H.F., et al. Aneuroprotective role for polyamines in a Xenopus tadpole model of epilepsy. Nat Neurosci 2011, 14:505-512.
279. Antony T., Hoyer W., Cherny D., et al. Cellular polyamines promote the aggregation of alpha-synuclein. JBiol Chem 2003, 278:3235-3240.
280. Goers J., Uversky V.N., Fink A.L. Polycation-induced oligomerization and accelerated fibrillation of human alpha-synuclein invitro. Protein Sci 2003, 12:702-707.
281. Mandal S., Mandal A., Johansson H.E., et al. Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells. Proc Natl Acad Sci USA 2013, 110(6):2169-2174.
282. Nishimura K., Shiina R., Kashiwagi K., et al. Decrease in polyamines with aging and their ingestion from food and drink. JBiochem 2006, 139:81-90.
283. Arshavsky Y.I. Alzheimer disease and cellular mechanisms of memory storage. JNeuropathol Exp Neurol 2014, 73(3):192-205.
284. Matthews H.R. Polyamines, chromatin structure and transcription. Bioessays 1993, 15(8):561-566.
285. Kondapalli K.C., Hack A., Schushan M., et al. Functional evaluation of autism-associated mutations in NHE9. Nat Commun 2013, 4:2510.
286. Zhu H.J., Appel D.I., Gründemann D., et al. Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action. Pharm Res 2012, 65(4):491-496.
287. Torres-Platas S.G., Hercher C., Davoli M.A., et al. Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology 2011, 36(13):2650-2658.
288. Gomes G.M., Mello C.F., da Rosa M.M., et al. Polyaminergic agents modulate contextual fear extinction in rats. Neurobiol Learn Mem 2010, 93(4):589-595.
289. Morrison L.D., Kish S.J. Brain polyamine levels are altered in Alzheimer's disease. Neurosci Lett 1995, 197(1):5-8.
290. Inoue K., Tsutsui H., Akatsu H., et al. Metabolic profiling of Alzheimer's disease brains. Sci Rep 2013, 3:2364.
291. Grabenauer M., Bernstein S.L., Lee J.C., et al. Spermine binding to Parkinson's protein alpha-synuclein and its disease-related A30P and A53T mutants. JPhys Chem B 2008, 112(35):11147-11154.
292. Lewandowski N.M., Ju S., Verbitsky M., et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci USA 2010, 107(39):16970-16975.
293. Paik M.J., Ahn Y.H., Lee P.H., et al. Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy. Clin Chim Acta 2010, 411(19-20):1532-1535.
294. Lesort M., Chun W., Tucholski J., et al. Does tissue transglutaminase play a role in Huntington's disease?. Neurochem Int 2002, 40(1):37-52.
295. Colton C.A., Xu Q., Burke J.R., et al. Disrupted spermine homeostasis: a novel mechanism in polyglutamine-mediated aggregation and cell death. JNeurosci 2004, 24:7118-7127.
296. Acevedo-Torres K., Berríos L., Rosario N., et al. Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. DNA Repair (Amst) 2009, 8:126-136.
297. Tong X., Ao Y., Faas G.C., et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat Neurosci 2014, 10.1038/nn.3691.
298. Gomes-Trolin C., Nygren I., Aquilonius S.M., et al. Increased red blood cell polyamines in ALS and Parkinson's disease. Exp Neurol 2002, 177(2):515-520.
299. Ferchmin P.A., Eterović V.A., Rivera E.M., et al. Spermine increases paired-pulse facilitation in area CA1 of hippocampus in a calcium-dependent manner. Brain Res 1995, 689(2):189-196.
300. Casero R.A., Pegg A.E. Polyamine catabolism and disease. Biochem J 2009, 421:323-338.
301. Fiori L.M., Wanner B., Jomphe V., et al. Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide. PLoS One 2010, 5(11):e15146.
302. Le Roy C., Laboureyras E., Laulin J.P., et al. Apolyamine-deficient diet opposes hyperalgesia, tolerance and the increased anxiety-like behaviour associated with heroin withdrawal in rats. Pharmacol Biochem Behav 2013, 103(3):510-519.
303. Gilad G.M., Gilad V.H. Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cell Mol Neurobiol 2003, 23(4-5):637-649.
304. Kossel A. Über das Agmatin. Zeitschrift für Physiologische Chemie 1910, 66:257-261. [in German].
305. Bardócz S., Duguid T.J., Brown D.S., et al. The importance of dietary polyamines in cell regeneration and growth. Br J Nutr 1995, 73(6):819-828.
306. Kalač P. Health effects and occurrence of dietary polyamines: a review for the period 2005-mid 2013. Food Chem 2014, 161:27-39.
307. Gorboulev V., Ulzheimer J.C., Akhoundova A., et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 1997, 16(7):871-881.
308. Kimura N., Masuda S., Katsura T., et al. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2. Biochem Pharmacol 2009, 77(8):1429-1436.
309. Becker M.L., Visser L.E., van Schaik R.H., et al. OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users. Neurogenetics 2011, 12(1):79-82.
310. Cui M., Aras R., Christian W.V., et al. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci USA 2009, 106(19):8043-8048.